Organon Pharma Indonesia Tbk. vs Agung Semesta Sejahtera Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Agung Semesta Sejahtera Tbk. trades at Rp32 (market cap 342.37B, 1.56M 24h volume). The key difference: Agung Semesta Sejahtera Tbk. is far larger — about 3.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TARA | |
|---|---|---|
Market Cap | 104.4B | 342.37B |
Volume | — | 1.56M |
Lot | — | 15.55K |
Turnover | — | 49.77M |
Average Price | — | 32 |
Value | — | 49.77M |
Indicative Equilibrium Price | — | 32 |
Indicative Equilibrium Volume | — | 76 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Sitara Propertindo Tbk (the Company) formerly PT Garda Jaya Prima was established based on Notarial Deed No. 2 dated July 28, 2006 of Patricia Bunandi Panggabean S.H., notary in Jakarta.
Read more on TARA →